SG10201708028VA - Method of making a mycoplasma vaccine - Google Patents

Method of making a mycoplasma vaccine

Info

Publication number: SG10201708028VA
Authority: SG; Singapore
Prior art keywords: making; mycoplasma vaccine; mycoplasma; vaccine
Prior art date: 2012-12-28

Application number

SG10201708028VA

Inventor

Dianna M Murphy Jordan

Brian Thomas Martinson

Christine Margaret Muehlenthaler

Axel Neubauer

Arun V Iyer

Original Assignee

Boehringer Ingelheim Vetmedica Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-28

Filing date

2013-12-20

Publication date

2017-10-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49917778&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201708028V(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-12-20 Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh

2017-10-30 Publication of SG10201708028VA publication Critical patent/SG10201708028VA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/70—Non-animal cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Immunology (AREA)
Cell Biology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Developmental Biology & Embryology (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

SG10201708028VA 2012-12-28 2013-12-20 Method of making a mycoplasma vaccine SG10201708028VA (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201261746997P	2012-12-28	2012-12-28

Publications (1)

Publication Number	Publication Date
SG10201708028VA true SG10201708028VA (en)	2017-10-30

Family

ID=49917778

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SG10201708028VA SG10201708028VA (en)	2012-12-28	2013-12-20	Method of making a mycoplasma vaccine
SG11201505089YA SG11201505089YA (en)	2012-12-28	2013-12-20	Method of making a mycoplasma vaccine

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SG11201505089YA SG11201505089YA (en)	2012-12-28	2013-12-20	Method of making a mycoplasma vaccine

Country Status (23)

Country	Link
US (2)	US9273281B2 (en)
EP (1)	EP2938747B1 (en)
JP (2)	JP6122146B2 (en)
KR (1)	KR102153275B1 (en)
CN (2)	CN104968365B (en)
AR (1)	AR094648A1 (en)
AU (1)	AU2013370983B2 (en)
BR (1)	BR112015012711B1 (en)
CA (1)	CA2896298C (en)
CL (1)	CL2015001562A1 (en)
DK (1)	DK2938747T3 (en)
EA (1)	EA032772B1 (en)
ES (1)	ES2738100T3 (en)
HU (1)	HUE045015T2 (en)
MX (1)	MX361273B (en)
MY (1)	MY173223A (en)
PH (1)	PH12015501333A1 (en)
PL (1)	PL2938747T3 (en)
PT (1)	PT2938747T (en)
SG (2)	SG10201708028VA (en)
TW (2)	TWI618542B (en)
UA (1)	UA121193C2 (en)
WO (1)	WO2014105672A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8546149B2 (en)	2010-08-27	2013-10-01	Intervet Inc.	Potency test for vaccine formulations
SG10201708028VA (en) *	2012-12-28	2017-10-30	Boehringer Ingelheim Vetmedica Gmbh	Method of making a mycoplasma vaccine
KR102355614B1 (en) *	2012-12-28	2022-01-27	베링거잉겔하임베트메디카게엠베하	Immunogenic composition comprising mycoplasma antigens
CN105441368B (en) *	2016-01-19	2019-01-01	福清市默克兽医院	One plant of Mycoplasma bovis and its application
EP3408281A4 (en) *	2016-01-29	2019-08-14	Advanced Animal Diagnostics, Inc.	Methods and compositions for detecting mycoplasma exposure
EP3498728A4 (en) *	2016-08-09	2020-03-25	Agricultural Technology Research Institute	Composition for preventing and treatingmycoplasma hyorhinis
US20180221407A1 (en) *	2017-02-03	2018-08-09	The Administrators Of The Tulane Educational Fund	Ophthalmic compositions for therapeutic and prophylactic uses
JP6828745B2 (en)	2017-05-24	2021-02-10	三菱ケミカル株式会社	Manufacturing method of sheet molding compound, fiber reinforced composite material and fiber reinforced composite material
WO2020251847A1 (en)	2019-06-10	2020-12-17	Elanco Us Inc.	Mycoplasma media formulations
CN113201050B (en) *	2020-08-06	2022-07-22	青岛诺安百特生物技术有限公司	Staphylococcus aureus bacteriophage perforin and preparation method and application thereof

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2909462A (en)	1955-12-08	1959-10-20	Bristol Myers Co	Acrylic acid polymer laxative compositions
GB1074920A (en) *	1965-04-21	1967-07-05	Pfizer & Co C	Growth medium for mycoplasma pneumoniae and vaccine production
GB1137306A (en) *	1966-07-11	1968-12-18	Research Corp	Inoculum for poultry
JPS5540568B2 (en)	1972-10-05	1980-10-18
US5338543A (en)	1992-02-27	1994-08-16	Ambico, Inc.	Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5885823A (en)	1995-06-05	1999-03-23	Nobl Laboratories, Inc.	Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
KR100797547B1 (en) *	2000-03-03	2008-01-24	자이단호진 가가쿠오요비겟세이료호겐쿠쇼	Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
JP3402304B2 (en) *	2000-03-30	2003-05-06	株式会社微生物化学研究所	Method for producing feline chlamydia vaccine
MY129765A (en)	2000-12-19	2007-04-30	Wyeth Corp	Improved mycoplasma hyopneumoniae bacterin vaccine
US7018638B2 (en)	2000-12-19	2006-03-28	Wyeth	Mycoplasma hyopneumoniae bacterin vaccine
US20030147914A1 (en)	2001-07-02	2003-08-07	Pfizer Inc.	Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
WO2003004051A2 (en)	2001-07-02	2003-01-16	Pfizer Products Inc.	Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
JP2005515162A (en)	2001-07-02	2005-05-26	ファイザー・プロダクツ・インク	Single vaccination with Mycoplasma hyopneumoniae
IL159145A0 (en)	2001-08-28	2004-06-01	Pfizer Prod Inc	Mycoplasma bovis challenge model, methods for administering m. bovis and methods for inducing pneumonic lung lesions
TWI238721B (en) *	2003-06-20	2005-09-01	Animal Technology Inst Taiwan	Swine enzootic vaccine, its producing method and usage
EP1846223A4 (en)	2005-02-09	2012-05-30	Magna Int Inc	Method of manufacturing a semi-structural panel
CA2601006C (en) *	2005-03-10	2012-10-23	Kyoritsu Seiyaku Corporation	Cell strain capable of being cultured without ingredients derived from animals, method of producing the same, method of producing virus using the same, and method of producing vaccine
JP2009512426A (en) *	2005-10-14	2009-03-26	イヴァン・ペテャエフ	Treatment and diagnosis of obligate intracellular pathogens
KR20140075022A (en)	2006-09-15	2014-06-18	메디뮨 엘엘씨	Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
US20090068231A1 (en)	2007-09-11	2009-03-12	Wyeth	Live attenuated mycoplasma strains
UY31437A1 (en)	2007-10-29	2009-05-29		MYCOPLASMA BOVIS VACCINE AND SAME USE METHODS
US9056909B2 (en)	2007-11-06	2015-06-16	Zoetis Services Llc	Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine
AU2009234345B2 (en)	2008-01-23	2013-08-22	Boehringer Ingelheim Vetmedica, Inc.	PCV2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
US8444989B1 (en)	2008-04-18	2013-05-21	Boehringer Ingelheim Vetmedica Gmbh	One dose vaccination against mycoplasma infections of pigs
JPWO2009142086A1 (en)	2008-05-23	2011-09-29	学校法人久留米大学	Vaccine composition for mycoplasma infection
SI2310046T1 (en)	2008-06-27	2016-05-31	Zoetis Services Llc	Novel adjuvant compositions
NZ591950A (en)	2008-10-31	2012-12-21	Boehringer Ingelheim Vetmed	Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
JP5744852B2 (en)	2009-05-19	2015-07-08	バイオプロパティーズピーティーワイリミテッド	Temperature sensitive vaccine strain of Mycoplasmahyopneumoniae and use thereof
US20110150770A1 (en)	2009-12-18	2011-06-23	Boehringer Ingelheim Vetmedica, Inc.	Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine
US8112663B2 (en)	2010-03-26	2012-02-07	Lsi Corporation	Method to establish redundancy and fault tolerance better than RAID level 6 without using parity
CN102258776B (en)	2011-07-07	2013-07-10	普莱柯生物工程股份有限公司	Combined inactivated vaccine against mycoplasma hyopneumoniae (MHP) and mycoplasma hyorhinis and preparation method thereof
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
UA114504C2 (en)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	PCV, MYCOPLASMA HYOPNEUMONIA AND PRRS COMBINED VACCINE
UA114503C2 (en)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	PCV AND MYCOPLASMA HYOPNEUMONIA COMBINED VACCINE
KR102355614B1 (en) *	2012-12-28	2022-01-27	베링거잉겔하임베트메디카게엠베하	Immunogenic composition comprising mycoplasma antigens
SG10201708028VA (en) *	2012-12-28	2017-10-30	Boehringer Ingelheim Vetmedica Gmbh	Method of making a mycoplasma vaccine

2013
- 2013-12-20 SG SG10201708028VA patent/SG10201708028VA/en unknown
- 2013-12-20 BR BR112015012711-8A patent/BR112015012711B1/en active IP Right Grant
- 2013-12-20 SG SG11201505089YA patent/SG11201505089YA/en unknown
- 2013-12-20 KR KR1020157020447A patent/KR102153275B1/en active IP Right Grant
- 2013-12-20 EP EP13817835.5A patent/EP2938747B1/en active Active
- 2013-12-20 MX MX2015007730A patent/MX361273B/en active IP Right Grant
- 2013-12-20 UA UAA201507463A patent/UA121193C2/en unknown
- 2013-12-20 PT PT13817835T patent/PT2938747T/en unknown
- 2013-12-20 CA CA2896298A patent/CA2896298C/en active Active
- 2013-12-20 US US14/135,796 patent/US9273281B2/en active Active
- 2013-12-20 DK DK13817835.5T patent/DK2938747T3/en active
- 2013-12-20 CN CN201380066001.XA patent/CN104968365B/en active Active
- 2013-12-20 MY MYPI2015001621A patent/MY173223A/en unknown
- 2013-12-20 JP JP2015549759A patent/JP6122146B2/en active Active
- 2013-12-20 EA EA201500701A patent/EA032772B1/en not_active IP Right Cessation
- 2013-12-20 AU AU2013370983A patent/AU2013370983B2/en not_active Ceased
- 2013-12-20 ES ES13817835T patent/ES2738100T3/en active Active
- 2013-12-20 PL PL13817835T patent/PL2938747T3/en unknown
- 2013-12-20 HU HUE13817835 patent/HUE045015T2/en unknown
- 2013-12-20 CN CN201810161003.1A patent/CN108379571A/en active Pending
- 2013-12-20 WO PCT/US2013/076807 patent/WO2014105672A1/en active Application Filing
- 2013-12-27 AR ARP130105050A patent/AR094648A1/en unknown
- 2013-12-27 TW TW102148875A patent/TWI618542B/en active
- 2013-12-27 TW TW107103700A patent/TWI660736B/en active
2015
- 2015-06-05 CL CL2015001562A patent/CL2015001562A1/en unknown
- 2015-06-15 PH PH12015501333A patent/PH12015501333A1/en unknown
2016
- 2016-01-19 US US15/000,342 patent/US10512680B2/en active Active
2017
- 2017-03-30 JP JP2017067820A patent/JP6449364B2/en active Active

Also Published As

Publication number	Publication date
PH12015501333A1 (en)	2015-09-02
CA2896298C (en)	2024-01-16
DK2938747T3 (en)	2019-08-05
JP2016508983A (en)	2016-03-24
HUE045015T2 (en)	2019-11-28
MY173223A (en)	2020-01-07
BR112015012711A2 (en)	2017-07-11
CA2896298A1 (en)	2014-07-03
MX2015007730A (en)	2015-09-07
SG11201505089YA (en)	2015-07-30
BR112015012711B1 (en)	2022-08-16
AR094648A1 (en)	2015-08-19
US10512680B2 (en)	2019-12-24
PT2938747T (en)	2019-08-01
TW201832777A (en)	2018-09-16
WO2014105672A1 (en)	2014-07-03
CN108379571A (en)	2018-08-10
JP6449364B2 (en)	2019-01-09
UA121193C2 (en)	2020-04-27
KR102153275B1 (en)	2020-09-09
JP6122146B2 (en)	2017-04-26
JP2017145253A (en)	2017-08-24
AU2013370983B2 (en)	2019-09-26
EP2938747A1 (en)	2015-11-04
EP2938747B1 (en)	2019-05-01
US9273281B2 (en)	2016-03-01
US20160136254A1 (en)	2016-05-19
US20140186394A1 (en)	2014-07-03
EA032772B1 (en)	2019-07-31
MX361273B (en)	2018-12-03
EA201500701A1 (en)	2015-12-30
CN104968365A (en)	2015-10-07
CL2015001562A1 (en)	2016-06-24
TWI618542B (en)	2018-03-21
KR20150100920A (en)	2015-09-02
TW201438732A (en)	2014-10-16
AU2013370983A1 (en)	2015-05-21
CN104968365B (en)	2018-04-03
TWI660736B (en)	2019-06-01
ES2738100T3 (en)	2020-01-20
PL2938747T3 (en)	2019-11-29

Publication	Publication Date	Title
HK1207967A1 (en)	2016-02-19	Vaccine
SG10201708028VA (en)	2017-10-30	Method of making a mycoplasma vaccine
GB2501243B (en)	2014-06-18	Method of making a medical balloon
EP2913831A4 (en)	2015-11-25	Rare-earth-magnet production method
EP2939754A4 (en)	2016-03-16	Draw forming method
EP2876161A4 (en)	2016-03-23	Vaccine
GB201223386D0 (en)	2013-02-06	Vaccine
IL234024A0 (en)	2014-09-30	Method of making a multilayr article
GB2517862B (en)	2017-03-01	Method of marking a line
PL2931937T3 (en)	2017-05-31	Method of producing metal-nanoparticle-arrays
PL2809816T3 (en)	2019-04-30	Expression method
SG11201504454RA (en)	2015-07-30	A method of vitrification
EP2824130A4 (en)	2015-10-14	Method for producing polydialkylsilane
GB201220155D0 (en)	2012-12-26	Method of manufacture
LU92341B1 (en)	2015-04-29	Method of producing a shaped component
SG2013017017A (en)	2014-09-26	A method of separation
HRP20181348T1 (en)	2018-11-16	Method of making a panel
SG2013085071A (en)	2014-07-30	Method of producing methionine
PL2662656T3 (en)	2015-10-30	Method of construction of a radiator
EP2832696A4 (en)	2015-11-04	Mayenite production method
GB201215942D0 (en)	2012-10-24	Method of treatent
GB201202090D0 (en)	2012-03-21	Vaccine
HK1208864A1 (en)	2016-03-18	A preparation method of ecteinascidin-743 intermediate -743
GB201215939D0 (en)	2012-10-24	Method of preparing monomers
EP2812301A4 (en)	2015-10-21	Method of producing alcohols